Literature DB >> 7641220

Lymphocytes infiltrating colorectal cancer have low proliferative capacity but can secrete normal levels of interferon gamma.

W J Bateman1, I Donnellan, I A Fraser, L S Wong, A G Morris.   

Abstract

Significant numbers of infiltrating mononuclear cells are commonly observed in solid tumours, although their role in restricting tumour growth is not clear. Tumour-infiltrating lymphocytes (TIL) from 38 patients with colorectal cancer, in parallel with peripheral blood lymphocytes (PBL), were assayed to determine their ability to proliferate in response to concanavalin A (ConA), interleukin-2 (IL-2), ConA+IL-2, phorbol 12-myristate 13-acetate (PMA)+ionomycin ionomycin (IOM), and staphylococcal enterotoxin B(SEB). These reagents were selected to give a range of weak to strong proliferative responses either via or independent of the T cell receptor. Proliferation of TIL was significantly lower than that of PBL in all cultures: ConA (P < 0.001), IL-2 (P = 0.002), ConA+IL-2 (P < 0.001), PMA+IOM (P < 0.001), SEB (P = 0.002). In addition to the low proliferative capacity of TIL, production of cytokines by TIL may also play a role in control of tumour growth. We have assayed IFN gamma production in the supernatants from 16 paired TIL and PBL cultures, and tumour necrosis factor alpha (TNF alpha) in 6 paired cultures. TNF alpha concentrations were significantly lower in TIL cultures than in PBL cultures stimulated with ConA (P < 0.05), but no different in control or IL-2 stimulated cultures. IFN gamma levels did not significantly differ between PBL and TIL cultures, indicating that despite the restricted proliferative capacity of TIL, these cells remain capable of secreting significant amounts of IFN gamma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641220     DOI: 10.1007/bf01788961

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  33 in total

Review 1.  The transforming growth factor-betas. A new family of immunoregulatory molecules.

Authors:  M A Palladino; R E Morris; H F Starnes; A D Levinson
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

2.  Characterization of activated lymphocytes in colon cancer.

Authors:  E C Ebert; R E Brolin; A I Roberts
Journal:  Clin Immunol Immunopathol       Date:  1989-01

3.  Source of unique tumour antigens.

Authors:  A Townsend; C Ohlén; M Rogers; J Edwards; S Mukherjee; J Bastin
Journal:  Nature       Date:  1994-10-20       Impact factor: 49.962

4.  Lymphoreticular cells within primary colorectal carcinoma: a surface marker study.

Authors:  J A Werkmeister; E Pihl; E S Hughes; A M Cuthbertson; A J Rollo
Journal:  Clin Immunol Immunopathol       Date:  1981-03

5.  Frequency of abnormal expression of HLA-A,B,C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumor recurrence.

Authors:  P Möller; K Koretz; P Schlag; F Momburg
Journal:  Int J Cancer Suppl       Date:  1991

6.  Functional characterization of tumor-infiltrating lymphocytes, lymph-node lymphocytes and peripheral-blood lymphocytes from patients with breast cancer.

Authors:  A Rubbert; B Manger; N Lang; J R Kalden; E Platzer
Journal:  Int J Cancer       Date:  1991-08-19       Impact factor: 7.396

7.  Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.

Authors:  S Yasumura; H Hirabayashi; D R Schwartz; J F Toso; J T Johnson; R B Herberman; T L Whiteside
Journal:  Cancer Res       Date:  1993-03-15       Impact factor: 12.701

8.  The analysis of mononuclear cell infiltrations in colorectal adenocarcinoma.

Authors:  B Koch; J Giedl; P Hermanek; J R Kalden
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

9.  CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion.

Authors:  R Dadmarz; M K Sgagias; S A Rosenberg; D J Schwartzentruber
Journal:  Cancer Immunol Immunother       Date:  1995-01       Impact factor: 6.968

10.  T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.

Authors:  M Sensi; S Salvi; C Castelli; C Maccalli; A Mazzocchi; R Mortarini; G Nicolini; M Herlyn; G Parmiani; A Anichini
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

View more
  3 in total

1.  Can immunotherapy by gene transfer tip the balance against colorectal cancer?

Authors:  S M Todryk; H Chong; R G Vile; H Pandha; N R Lemoine
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

2.  Interleukin 2 restores CD3-zeta chain expression but fails to generate tumour-specific lytic activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metastases.

Authors:  K F Yoong; D H Adams
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

3.  Histocompatibility leukocyte antigen-A2402-restricted cytotoxic T lymphocytes recognizing adenocarcinoma in tumor-infiltrating lymphocytes of patients with colon cancer.

Authors:  R Gohara; M Nakao; Y Ogata; H Isomoto; K Oizumi; K Itoh
Journal:  Jpn J Cancer Res       Date:  1997-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.